Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 3 to 10

Folinic Acid for Autism in Children (2 mg/kg/day)

Official title: Folinic Acid as a Treatment for Autism Spectrum Disorder in Children: A Double-blind Randomised Placebo-controlled Trial With Open Label Extension (FOLIN-A Trial)

Run by KK Women's and Children's Hospital · NCT07630506 · Data updated 2026-11-12

This study tests whether folinic acid given to children with autism helps improve symptoms compared with a placebo.

More Autism Spectrum Disorder trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages3 Years to 10 Years
SexAll
Enrollment184 (estimated)
SponsorKK Women's and Children's Hospital
Government
Drugs / interventionsmethotrexate
Locations1 site (Singapore, Singapore)
StatusRecruiting
StartedMay 19, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJune 5, 2026
Trial IDNCT07630506 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 through 10 years 11 months with a confirmed ASD diagnosis, stable behavioral interventions, and weight between 10 and 30 kg.

Probably not a fit

Children who do not respond to folinic acid or who experience adverse effects may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a phase 2, double-blind, randomized, placebo-controlled trial in children with autism spectrum disorder. Participants will receive either folinic acid 2 mg/kg/day or a matching placebo for 12 weeks, without anyone knowing which treatment is being given. After the blinded period, all participants may receive folinic acid during a 12-week open-label extension to examine longer-term safety and potential benefits. The trial aims to determine if folinic acid can improve core autism symptoms and overall functioning in children.

Why it matters

Potential benefit: If successful, children may experience improvements in communication, behavior, and social interaction.

How similar studies have gone: Prior similar trials in this area have explored folate-related therapies, with mixed results; this study contributes additional evidence in a rigorous design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 3 years 0 months to 10 years 11 months at the time of enrolment
* Weight ≥ 10 kg and ≤ 30 kg at the time of enrolment
* Confirmed diagnosis of Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, supported by standardized diagnostic assessments
* Stable on regular behavioral interventions and any medications for at least 6 months prior to enrolment
* At least one parent or legal guardian able to understand and complete study questionnaires in English
* Written informed consent obtained from a parent or legal guardian

Exclusion Criteria:

* Known allergy or intolerance to folinic acid
* Current or prior supplementation with folinic acid or other folate preparations (folic acid supplementation permitted)
* Vitamin B12 (cobalamin) deficiency or pernicious anemia
* Concurrent use of medications known to interfere with folate metabolism (e.g., methotrexate, trimethoprim, fluorouracil, capecitabine, glucarpidase)
* Known genetic, metabolic, or chromosomal disorder, or structural brain abnormalities
* History of epilepsy or seizures (except simple febrile seizures) or current use of antiepileptic or antipsychotic medication
* Significant sensory (hearing or visual) or motor impairment
* Participation in another interventional clinical trial for autism within the past 6 months
* Unable or unwilling to comply with study visits and procedures

Where it's running

  • KK Women's and Children's Hospital
    Singapore, Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.